1. Home
  2. ACB vs QSI Comparison

ACB vs QSI Comparison

Compare ACB & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

HOLD

Current Price

$4.06

Market Cap

250.1M

Sector

Health Care

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$1.10

Market Cap

273.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACB
QSI
Founded
2013
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.1M
273.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACB
QSI
Price
$4.06
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.63
AVG Volume (30 Days)
1.1M
4.9M
Earning Date
02-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$263,570,704.00
$3,177,000.00
Revenue This Year
$11.82
N/A
Revenue Next Year
$8.58
$159.68
P/E Ratio
N/A
N/A
Revenue Growth
23.89
40.20
52 Week Low
$3.42
$0.95
52 Week High
$6.91
$3.10

Technical Indicators

Market Signals
Indicator
ACB
QSI
Relative Strength Index (RSI) 40.91 37.29
Support Level $3.88 $1.14
Resistance Level $4.47 $1.33
Average True Range (ATR) 0.14 0.07
MACD -0.01 -0.01
Stochastic Oscillator 29.75 16.07

Price Performance

Historical Comparison
ACB
QSI

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Share on Social Networks: